FDA clears narrow use of Lynparza in early prostate cancer — AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral --FDA approves Pfizer’s RSV vaccine for older adults -- See more on our front page news http://bit.ly/w28kSd See more on our front page news
Dismiss Notice

Reply to Thread

Verification:: Answer the above question:

(CustomImgCaptcha By Surrey Forum)

Message:: [QUOTE="Anonymous, post: 3937228"]What flavor is that kool-aid you're drinking?  You must be one of our weak Acclarent managers who has never made a number (yes I'm talking to you) yet still managed to get promoted (sometimes even TWICE-Salkeld). JNJ isn't leaving management alone this year-keep hiding behind Q1-how are your Q2 numbers looking?  Down? In-Office? No reimbursement? That slippery slope has already started.   Sadly, you are such a poor manager that you can't see that one good quarter is hardly the redemption you'll need to save your ass this year. Best year on record since 2009? (did you hurt yourself typing that?) JNJ is finally starting to ask the right questions ABOUT management.[/QUOTE]